Filing metadata

Accession number
0000950170-24-120214
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Nov 01, 2024
Reporting period
Nov 01, 2024
Description
Insider transaction

Explore SEC Filings Hub